Repligen | RGEN - Umlaufvermögen

Aktienkurs
117.60
Täglich Wechseln
3.54 3.10%
Monatlich
2.87%
Jährlich
-18.76%
Q2 Prognose
115.08




Umlaufvermögen Veränderung Datum
Agilent USD 4.62B 21M 2025-12
Align Technology USD 2.62B 82.47M 2025-12
Bio Techne USD 637.43M 27.92M 2025-12
BioMarin Pharmaceutical USD 3.95B 98.95M 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Bruker USD 2.21B 138.1M 2025-12
Charles River Laboratories USD 1.45B 85.06M 2025-12
Danaher USD 13.94B 1.18B 2026-03
Dentsply International USD 2.02B 49M 2025-12
General Electric Aerospace USD 40.36B 235M 2026-03
Henry Schein USD 4.46B 69M 2025-12
Illumina USD 3.29B 493M 2025-12
IQVIA Holdings USD 6.25B 270M 2025-12
Mettler Toledo International USD 1.36B 81.46M 2025-12
Myriad Genetics USD 332.6M 12.2M 2025-12
OraSure Technologies USD 261.91M 21.1M 2025-12
Pacific Biosciences Of California USD 375.05M 19.18M 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Repligen USD 1.14B 40.9M 2025-12
Revvity USD 2.24B 95.96M 2025-12
Standard Biotools USD 454.26M 18.18M 2025-12
Thermo Fisher Scientific USD 22.32B 6.39B 2026-03
Waters USD 1.99B 69.86M 2025-12
West Pharmaceutical Services USD 1.83B 151.4M 2026-03